SCHEMBL12123371

SCHEMBL12123371

Cc1ccc(-c2cc3cc4c(cc(-c5ccc(C)cc5)n4-c4ccc(N(c5ccc(C)cc5)c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4)cc3n2-c2ccc(N(c3ccc(C)cc3)c3ccc4c(c3)c3ccccc3n4-c3ccccc3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ PTGER4 P35408 1/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ GAA P10253 2/20 0.38
▸ APP P05067 1/20 0.38
▸ RAC2 P15153 1/20 0.36
▸ RAC3 P60763 1/20 0.36
▸ CDC42 P60953 1/20 0.36
▸ RAC1 P63000 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ NPY5R Q15761 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ AKR1C4 P17516 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12123358 0.99 KDM4E (0.38) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123372 0.98 CYP2C9 (0.40) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123394 0.98 CYP2C9 (0.40) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123370 0.98 CYP2C9 (0.41) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123379 0.95 RXFP1 (0.38) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123368 0.95 RXFP1 (0.38) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123377 0.93 KDM4E (0.35) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123396 0.92 L3MBTL1 (0.42) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL12123401 0.92 L3MBTL1 (0.42) KDM4EATML3MBTL1CYP2C9HTT
SCHEMBL14900847 0.92 KDM4E (0.44) KDM4EATML3MBTL1PTGER4APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8057920-B2 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-15 — — US disclosed
US-8057920-B2 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-15 — — US disclosed
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-06-11 — — US disclosed
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same TRPC1, TRPC3, TRPC4 KDM4E 4097/4885ATM 3666/4885L3MBTL1 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback